USE OF MYCOBACTERIUM W IN TREATMENT OF BRONCHIAL ASTHAMA
Application 246/MUM/2002 published 2006-09-01, filed 2002-03-13
A method of treating asthma (obstructive lung disease) comprises administration of a formulation which is prepared using Mycobacterium w or a pharmaceutical composition obtained from Mycobacterium w alone or in combination and also with or without adjuvants to a subject suffering from tuberculosis. Drawing: NIL Total Pages: 19 Fig. Nil
Applicant
CADILA PHARMACEUTICALS LTD.
“CADILA CORPORATE CAMPUS”, SARKHEJ-DHOLKA ROAD, BHAT, AHMEDABAD, 382210, GUJARAT, INDIA
Inventor
1. DR RAJIV I. MODI 2. DR. BAKULESH MAFATLAL KHAMAR
International Info
Classification: A61K 31/00, C07D 473/00